Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization - Topol, EJ; Moliterno, DJ; Herrmann, HC (N Engl J Med, 2001)
et al.